These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18929425)

  • 21. [Tumor suppressor gene PTEN and non-alcoholic steatohepatitis (NASH)].
    Sato W; Horie Y; Watanabe S; Suzuki A
    Nihon Rinsho; 2005 Aug; 63(8):1475-83. PubMed ID: 16101243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
    Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice.
    Watanabe S; Horie Y; Kataoka E; Sato W; Dohmen T; Ohshima S; Goto T; Suzuki A
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S96-S100. PubMed ID: 17567478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steatohepatitic hepatocellular carcinoma: imaging findings with clinicopathological correlation.
    Inui S; Kondo H; Tanahashi Y; Fukukura Y; Sano K; Morisaka H; Saito K; Kondo F; Fukusato T; Furui S; Oba H
    Clin Radiol; 2021 Feb; 76(2):160.e15-160.e25. PubMed ID: 33046228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
    Tiniakos DG
    Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver carcinogenesis associated with feeding of ethionine in a choline-free diet: evidence against a role of oval cells in the emergence of hepatocellular carcinoma.
    Tarsetti F; Lenzi R; Salvi R; Schuler E; Rijhsinghani K; Lenzen R; Tavoloni N
    Hepatology; 1993 Sep; 18(3):596-603. PubMed ID: 8359801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.
    Chalasani N; Wilson L; Kleiner DE; Cummings OW; Brunt EM; Unalp A;
    J Hepatol; 2008 May; 48(5):829-34. PubMed ID: 18321606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
    Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
    J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation.
    Takeuchi-Yorimoto A; Noto T; Yamada A; Miyamae Y; Oishi Y; Matsumoto M
    Toxicol Appl Pharmacol; 2013 May; 268(3):264-77. PubMed ID: 23481610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a long-term high-fat diet and switching from a high-fat to low-fat, standard diet on hepatic fat accumulation in Sprague-Dawley rats.
    Omagari K; Kato S; Tsuneyama K; Inohara C; Kuroda Y; Tsukuda H; Fukazawa E; Shiraishi K; Mune M
    Dig Dis Sci; 2008 Dec; 53(12):3206-12. PubMed ID: 18465233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is ultrasound-guided fine-needle biopsy effective for diagnosis of early HCC in liver cirrhosis?
    Schölmerich J
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):16-7. PubMed ID: 16265093
    [No Abstract]   [Full Text] [Related]  

  • 35. Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case.
    Nagaya T; Tanaka N; Komatsu M; Ichijo T; Sano K; Horiuchi A; Joshita S; Umemura T; Matsumoto A; Yoshizawa K; Aoyama T; Kiyosawa K; Tanaka E
    Clin J Gastroenterol; 2008 Oct; 1(3):116-121. PubMed ID: 26193649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
    Nakano T; Cheng YF; Lai CY; Hsu LW; Chang YC; Deng JY; Huang YZ; Honda H; Chen KD; Wang CC; Chiu KW; Jawan B; Eng HL; Goto S; Chen CL
    J Hepatol; 2011 Aug; 55(2):415-25. PubMed ID: 21184788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rabbit model for the study of human NASH].
    Otogawa K; Kawada N
    Nihon Rinsho; 2006 Jun; 64(6):1043-7. PubMed ID: 16768107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NASH (Nonalcoholic steatohepatitis): A case of multiorganelle failure.
    Caldwell S
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S6. PubMed ID: 26461413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
    Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T
    Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.